Breaking the “Black Box” in Bioprocessing
May 14, 2026
Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development
9 min read
False
Advertisement
Technology & Manufacturing
Industrializing Organoids to Bridge the Predictability Gap
By Priya Baraniak
May 11, 2026
As regulators move away from animal testing, scalable organoid platforms and standardized iPSC inputs could help close the gap between preclinical models and human biology
4 min read
Roving Reporter Asks: Where Do You See the Most Progress in CGT Manufacturing and Scalability?
May 6, 2026
IBTV speaks with industry leaders at the 2025 Meeting on the Mesa to explore advances in scaling cell and gene therapies
Trends and Challenges in Nitrosamine Testing: Part Five – Pharma’s Future
May 1, 2026
Our gurus return to discuss future directions for nitrosamine analysis and regulation within the pharmaceutical industry
3 min read
Manufacturing Viral Vectors for the Next Phase of CGT
April 30, 2026
As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success
7 min read
Trends and Challenges in Nitrosamine Testing: Part Three – Building a Method
April 24, 2026
Following part two, which explored the analytical challenges involved in nitrosamine testing, our experts return to offer their top tips for building a method from scratch
4 min read
Sartorius Unveils Platform Aimed at Scaling Autologous Cell Therapy
April 7, 2026
New Eveo system is designed to raise CAR-T output, cut manufacturing costs, and ease cleanroom bottlenecks
1 min read
Review: Making Better Antibodies at Scale
April 6, 2026
A new review unpacks how GMP standards, evolving regulations, and emerging production technologies are reshaping monoclonal antibody manufacturing
3 min read
Trends and Challenges in Nitrosamine Testing: Part One – Scoping the Problem
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
What I Learned Bringing Slalom Chromatography Back from the Dead
March 25, 2026
Fabrice Gritti spent a year immersed in the world of DNA physics to resurrect a long-abandoned technique to solve modern challenges in cell and gene therapy analysis
6 min read
